Introduction
In the multicellular organism, genetically regulated mechanisms determine not only which cells live, but also which cells die [1] . In the adult, steady-state condition, cell division must be counterbalanced by cell death. This physiologically important cell death is an active process, known as programmed cell death, or apoptosis. Apoptosis is characterized by profound morphological alterations of the cell and, specifically, the nucleus. Typically, apoptotic changes include cellular shrinkage, membrane blebbing and chromatin condensation [2] . The nuclear DNA of apoptotic cells is often fragmented into oligonucleosomalsized units [3] . By contrast, 'accidental' cell death, or necrosis, is caused by an overwhelming injury resulting in cellular swelling and loss of membrane integrity [4] .
Cell proliferation has been studied extensively, but genes regulating cell death have only recently attracted the attention of the biomedical research community. Perturbations of apoptosis contribute to the pathogenesis of several human diseases including cancer, acquired immunodeficiency syndrome and neurodegenerative disorders [5] . Thus, discovering ways to modulate apoptosis may have immense therapeutic potential. The fundamental importance of the cell-death pathway is further emphasized by its conservation throughout evolution [6] . In fact, genetic studies of two invertebrates, Caenorhabditis elegans and Drosophila melanogaster, have provided the most insight into the genes controlling apoptosis [7] . In this review, we focus on the effectors, inhibitors and activators of the celldeath pathway, and how they may function as a fine-tuned cell-suicide machine. We shall not discuss certain important regulators of apoptosis, such as p53, Rb and c-Myc, which have been covered in other recent reviews [8, 9] .
The engine of cell death
It is becoming apparent that proteases play an important part in the apoptotic mechanism [10] . Protease inhibitors of various specificities have been shown to inhibit cell death [11] . Furthermore, granzyme B, an aspartate-specific serine protease, is an important component of cytotoxic Tcell-mediated apoptosis [12, 13] . Purified granzyme B, in combination with perforin, a pore-forming protein, induces rapid apoptosis of various target cell lines [14] .
Systematic genetic studies of C. elegans have provided more direct evidence that proteases comprise the effector arm of the cell death pathway. Two genes, ced-3 and ced-4, are required for all somatic cell deaths that occur during nematode development [15] . Mutations of ced-3 and ced-4 abolish the apoptotic capability of cells that would otherwise be destined to die during C. elegans embryogenesis [16] . No homologs of the CED-4 protein have yet been identified, but numerous relatives of CED-3 have been characterized and comprise a new family of cysteine proteases.
The first mammalian homolog of CED-3 identified was interleukin-1␤ (IL-1␤) converting enzyme (ICE), a cysteine protease responsible for the processing of pro-IL-1␤ to the active cytokine [17] . Like granzyme B, ICE has the unusual property of cleaving after aspartate residues [18] . Overexpression of ICE or CED-3 in Rat-1 fibroblasts induces apoptosis, suggesting that ICE is functionally, as well as structurally, related to CED-3 [19] . However, such evidence is not conclusive, as ectopic expression of a number of proteases including chymotrypsin, proteinase K and trypsin cause significant apoptosis [20] .
Subsequent studies have suggested that proteases related to ICE might be more important than ICE itself in the apoptotic mechanism. First, a number of cell types stably secrete mature IL-1␤ without undergoing apoptosis. Second, ICE-deficient mice, although unable to generate active IL-1␤, do not have any obvious defects in apoptosis, except possibly in the apoptotic pathway induced by engagement of the cell-surface receptor Fas/APO-1 [21, 22] . Third, in an in vitro model of apoptosis, extracts prepared from chicken DU249 cells failed to cleave the primary substrate of ICE, pro-IL-1␤ [23] ; instead, a proteolytic activity in these extracts, termed prICE, cleaved the well-characterized 'death substrate' poly (ADP-ribose) polymerase (PARP) into fragments characteristic of apoptosis [23] . Purified ICE failed to cleave PARP [23, 24] , suggesting that prICE is distinct from ICE.
To date, six mammalian homologs of CED-3 and ICE have been characterized, including Nedd-2/ICH1 [25, 26] , Yama/CPP32/apopain [24, 27, 28] , Tx/ICH2/ICE rel-II [29] [30] [31] , ICE rel-III [29] , Mch2 [32] , and ICE-LAP3/ Mch3/CMH-1 [33] [34] [35] . On the basis of searches of the 'expressed sequence tagged' (EST) database of sequences from expressed human genes (C. Vincenz, H. Duan, V.M.D., unpublished observation), there are at least three additional mammalian ICE/CED-3 homologs. Three subfamilies of the ICE/CED-3 family have been defined ( Fig.  1) : Yama, ICE-LAP3, and Mch2 are closely related to C. elegans CED-3 and comprise the CED-3 subfamily; ICE, ICE rel II and ICE rel III form the ICE subfamily; and ICH1 and its mouse homologue, NEDD-2, form the NEDD-2 subfamily. All family members so far characterized contain an active site QACRG pentapeptide and are expressed in a broad range of tissues, developmental stages and cell lines. Ectopic expression of these ICE/CED-3 homologs in a variety of cells causes apoptosis.
An important advance came with the discovery that Yama, unlike ICE, efficiently cleaves the death substrate PARP into fragments characteristic of apoptosis [24, 28] . Activated Yama was biochemically purified from THP-1 cells using the Ac-DEVD-CHO tetrapeptide aldehyde corresponding to the amino acids of the PARP cleavage site [28] . This peptide was used to remove active Yama, and presumably other Yama-like proteases, from apoptotic osteosarcoma cell extracts, abrogating their apoptotic potential in vitro. This apoptotic activity could be restored by adding back purified Yama to the depleted extracts [28] . Taken together, these observations suggest that Yama may be the physiological PARP-cleaving enzyme (prICE), and may serve as the mammalian equivalent of CED-3.
Soon after these results on Yama came the discovery that Mch2 and ICE-LAP3 also cleave PARP efficiently [32, 34, 35] . Interestingly, both proteases are in the same subfamily -the CED-3 subfamily -as Yama (Fig. 1) . Furthermore, ICE-LAP3 is inhibited by the Ac-DEVD-CHO tetrapeptide aldehyde with similar kinetics to those shown by Yama [34, 35] . Thus, the PARP-cleavage activity of apoptotic cells (prICE) may actually be carried out by more than one ICE-like protease, suggesting redundancy in the cell-death pathway. As expected, CED-3 was shown to function as a cysteine protease [36, 37] . Like Yama and ICE-LAP3, CED-3 cleaves PARP more efficiently than it cleaves pro-IL-1␤, and it is also inhibited by Ac-DEVD-CHO [37] .
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Figure 1
Phylogenetic analysis of the ICE/CED-3 family of cysteine proteases, which can be subdivided into three groups. Sequences were aligned using the DNASTAR Align program. 
NEDD-2 subfamily
If members of the ICE/CED-3 family are involved in the cell-death pathway, they should be activated by apoptotic death stimuli. Like the family prototype, ICE, other members of the ICE/CED-3 family are synthesized as proenzymes which are proteolytically processed to form active heterodimeric enzymes [18] . Yama is expressed as a 32 kDa precursor, and upon activation it is processed into p17 and p12 subunits [28] . As predicted, Yama is activated upon receipt of various apoptotic stimuli, such as engagement of the Fas/APO-1 receptor [38, 39] , or treatment with the broad-spectrum protein kinase inhibitor staurosporine [38] . Furthermore, granzyme B can directly activate Yama, suggesting a potential mechanism for cytotoxic T-cellinduced apoptosis [40, 41] . Like Yama, ICE-LAP3 and Mch2 are activated by a variety of apoptotic stimuli ( [33, 38] and K. Orth, personal communication), implying that the ICE-like proteases most related to CED-3 ( Fig. 1 ) are important components of the cell-death machinery (Fig. 2) . Thus, mammals, unlike the nematode, may possess an arsenal of CED-3-like proteases able to transmit the death signal. These apoptotic proteases may each cleave a specific 'death substrate', form redundant pathways or comprise a proteolytic cascade.
Given that mammalian CED-3 homologs are apoptotic effectors, what are their substrates? Importantly, which substrates must be cleaved to drive cells into apoptosis? As discussed earlier, PARP, one of the best-characterized death substrates, is cleaved during many, if not all, forms of apoptosis [24, 42] . Cleavage of PARP is probably not directly important in the cell-death mechanism, as PARPdeficient mice develop normally and do not show significant perturbations of apoptosis [43] . The list of death substrates and potential targets for ICE-like proteases is growing and includes the nuclear lamins [44, 45] , the 70 kDa component of U1 small nuclear ribonucleoprotein (U1-70 kDa snRNP) [46, 47] , D4 guanine nucleotide dissociation inhibitor (D4-GDI) [48] , sterol regulatory element binding proteins (SREBPs) [49] and protein kinase C ␦ (PKC␦) [50] . It is not yet clear whether the cleavage of any of these substrates is important in the execution phase of apoptosis.
As mentioned, profound morphological alterations of the nucleus are a hallmark of apoptosis, and ICE-like proteases may have an important role here. The nuclear lamins are cleaved early during apoptosis [45] . Lamins are intermediate filament proteins that provide a structural framework for the inner nuclear membrane. Recent studies suggest that an ICE-like enzyme distinct from Yama/CPP32 may be responsible for lamin proteolysis [44] . Incubation with the ICE inhibitor YVAD chloromethyl ketone blocked lamin cleavage, PARP cleavage and DNA fragmentation in nuclei added to apoptotic cell extracts. Interestingly, only lamin cleavage was susceptible to inhibition by tosyl-L-lysl chloromethyl ketone (TLCK) [44] . This selective inhibition also partially blocked the morphologic transformation of added nuclei [44] . These observations provide further evidence for the involvement of multiple ICE/CED-3 family members in the apoptotic mechanism (Fig. 2) .
What is the subcellular localization of ICE/CED-3 family members? Enucleated cells treated with various death stimuli undergo the morphological changes associated with apoptosis, suggesting the cell-death machinery resides outside the nucleus [51, 52] . Indeed, pro-Yama and pro-ICE-LAP3 have been localized to the cell cytoplasm ( [33] and our unpublished observation). By contrast, active ICE localizes to the external surfaces of the plasma membrane, further emphasizing the role of ICE in IL-1␤ processing and secretion rather than apoptosis [53] . But if the cell-death machinery is cytoplasmic, it is unclear how it gains access to the nucleus to initiate DNA fragmentation, chromatin condensation and the cleavage of several nuclear death substrates, including PARP, U1-70 kDa and the nuclear lamins. Interestingly, active granzyme B has been localized to the nucleus [54] . It will be important to Review Regulation of cell death 557
Figure 2
The cell-death machinery. Apoptotic stimuli lead to the processing of CED-3-like apoptotic proteases, generating their active, heterodimeric forms. The consequences of protease activation are also shown. 
Braking cell death
The C. elegans model system has also provided insight into the negative regulators of the cell-death pathway ( Table  1 ). The ced-9 gene antagonizes the function of ced-3 and ced-4 by blocking cell death [55] . Importantly, CED-9 is homologous to Bcl-2, the prototypic member of a growing family of cell-death regulators [56] . First identified for its role in B-cell malignancies, bcl-2 when overexpressed inhibits cell death induced by a variety of apoptotic stimuli and in numerous cell types [57] . The fact that bcl-2 can substitute functionally for ced-9, preventing cell death in the nematode, further emphasizes the highly conserved nature of the cell-death machinery [56] .
The Bcl-2 family is comprised of both inhibitors of cell death, such as Bcl-2 and Bcl-x L , and promoters of cell death, such as Bax and Bak [9, 58, 59] . The question of how the negative regulators Bcl-2 and Bcl-x L function relative to the death-promoting members of the Bcl-2 family is a controversial one. Importantly, Bcl-2 family members can form homodimers and heterodimers [59, 60] . It was originally proposed that Bax (and presumably Bak) directly engages the cell-death machinery, whereas Bcl-2 and Bcl-x L merely antagonize this interaction [61] . Supporting this contention, mutant forms of Bcl-2 that fail to heterodimerize with Bax and Bak lose their ability to protect cells from apoptosis [61] . Recently, however, Cheng et al. [62] have identified mutant forms of Bcl-x L that fail to interact with Bax or Bak, but still maintain death-inhibiting activity, arguing for the existence of a Bax/Bak-independent cell-death pathway. These recent findings would support a model in which Bax and Bak promote cell death by sequestering Bcl-2 and Bcl-x L , preventing these negative regulators from binding and inhibiting their intended target.
Where do Bcl-2 and CED-9 function relative to members of the CED-3 family? Genetic evidence in C. elegans suggests that CED-9 functions upstream of the death effectors CED-3 and CED-4, preventing their activation [63, 64] . The molecular order of the cell-death pathway has been confirmed biochemically in mammalian cells [38] . It was demonstrated that Bcl-2 and Bcl-x L prevent the proteolytic activation of the mammalian CED-3 homologs Yama, ICE-LAP3 and Mch2 ( [38] , and A.M.C., unpublished data), suggesting that Bcl-2/Bcl-x L function upstream of the apoptotic proteases (Fig. 3 ). Molecular ordering of the celldeath pathway will hopefully help explain how members of the Bcl-2 family function.
Other negative regulators of cell death have been discovered in the course of research on viruses. It is not surprising that viruses have mastered the art of keeping cells alive, for it is in their interest to maintain the cell 'factories'
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Figure 3
Regulation of the mammalian CED-3 homologs. The apoptotic activator shown is a death-domain protein functionally related to Drosophila Reaper, but it could also be considered a generic death signal. Table 1 Negative regulators of the cell-death pathway.
Protein Function CED-9 Important inhibitor of cell death in C. elegans, homologous to Bcl-2 [55, 56] .
Bcl-2 family Some family members, such as Bcl-2 and Bcl-x L, inhibit cell death, whereas others, such as Bax and Bak, promote cell death [9, 58, 59] p35 Baculovirus protein that inhibits cell death in mammals, insects and nematodes. Its target is likely ICE/CED-3 family members [36, 81, 83] CrmA (SPI-2) Cowpox serpin that inhibits ICE, ICE-like proteins and granzyme B. Can block apoptosis induced by growth factor withdrawal [72] , TNF [73] , Fas [73] [74] [75] , and poxvirus infection [71] .
SPI-1 A poxvirus serpin likely having an enzyme specificity distinct from CrmA; inhibits poxvirus-induced apoptosis [71] .
IAP family
Inhibitors of apoptosis; baculovirus, Drosophila and human homologs identified [82, 85, 86] .
NAIP
Inhibitor of cell death induced by various apoptotic stimuli, including TNF; product of candidate gene responsible for spinal muscular atrophy, and related to IAPs [86, 88] .
Dad1
Protein that inhibits cell death; mammalian and C. elegans homologs identified [110, 111] .
A20
Mammalian protein that inhibits TNF-induced apoptosis but not Fas-induced apoptosis [112, 113] .
that produce their progeny. Viral counterparts of Bcl-2 include the adenovirus protein E1B-19 kDa [65, 66] and the Epstein Barr virus protein BHRF-1 [67] . Expression of Bcl-2 or E1B-19 kDa inhibits Yama activation and apoptosis induced by E1A [68] . Proteins unrelated to Bcl-2 that inhibit cell death and are harbored by viruses include CrmA, p35 and the IAPs.
CrmA is a cowpox serpin that inhibits ICE-like proteases and granzyme B [24, 69, 70] . However, ICE is inhibited by CrmA at much lower concentrations than is Yama, ICE-LAP3 or granzyme B [28, 34] . CrmA blocks cell death induced by viral infection [71] , growth-factor withdrawal [72] , treatment with tumor necrosis factor (TNF) [73] and engagement of Fas/APO-1 [73] [74] [75] . When CrmA-expressing cells are treated with anti-Fas antibody, both Yama and ICE-LAP3 remain as inactive pre-enzymes, suggesting that CrmA inhibits an ICE-like enzyme upstream of Yama and ICE-LAP3 [38] . This hypothesis is especially attractive considering that ICE has been shown to process Yama into active subunits [24] . The role of ICE in the Fas pathway is supported by the observation that thymocytes from ICE-deficient mice are resistant to Fasinduced cell death [22] . Significantly, however, ICEdeficient mice do not exhibit the lymphoproliferative phenotype [21, 22] characteristic of mice that carrying a defect in the fas gene [76] . We postulate that ICE, or more likely a member of the ICE subfamily ( Fig. 1) , acts as the CrmA target and functions upstream of Yama and the Yama-related proteases (Fig. 2) .
Baculovirus p35 is another viral inhibitor of apoptosis and is remarkable in that it can block cell death in mammals, insects and nematodes, suggesting that its target of action is evolutionarily conserved [77] [78] [79] [80] . Recent studies suggest that p35 functions by directly inhibiting ICE/CED-3 family members [36, 81] . Although p35 is specifically cleaved by ICE-like proteases, its mechanism of action is unclear. Unlike CrmA, p35 is not related to the serpin family of protease inhibitors. It is not yet known whether one or more ICE/CED-3 family members are targeted by p35 in mammalian cells.
The inhibitors of apoptosis -IAPs -constitute another family of cell-death suppressors that have been abducted by viruses [82, 83] . Like p35, viral IAPs (from Orgyia pseudotsugata and Cydia pomonella granulosis) block cell death induced by baculovirus infection and other apoptotic stimuli [82] [83] [84] , but their mechanism of action is not known. Recently, cellular homologs of the viral IAPs have been identified in Drosophila and in mammals. In Drosophila, DIAP1 was identified in a search for mutations that enhance cell death triggered by the reaper gene (see below), whereas DIAP2 was identified by a subsequent Genbank search [85, 86] . Transgenic flies expressing the Drosophila IAPs are partially protected from cell death [85] .
Mammalian homologs of the IAPs have recently been identified by two groups. Rothe et al. [87] showed that c-IAP1 and c-IAP2 are components of the tumor necrosis factor receptor-2 (TNFR-2) signalling complex, which includes two TNFR-associated factors (TRAF1 and TRAF2). By searching the Genbank database, Liston et al. [86] isolated the genes for the same IAPs, along with an additional mammalian IAP family member, xIAP. Importantly, these mammalian IAPs inhibit cell death induced by a number of apoptotic stimuli [86] . The baculoviral inhibition of apoptosis protein repeat (BIR) domain, which is the motif most conserved among species, likely mediates the inhibition of cell death by the IAPs [82] .
The gene encoding NAIP, a protein with homology to the IAPs, was shown to be partially deleted in individuals with spinal muscular atrophy (SMA), a common fatal autosomal recessive disorder [88] . It has been postulated that SMA is caused by inappropriate motor neuron apoptosis resulting from the absence of a functional cell-death inhibitor. Consistent with this hypothesis, overexpression of NAIP inhibits apoptosis induced by a variety of stimuli [86] . The human IAPs and NAIP are emerging as a new class of endogenous mammalian cell-death suppressors, an area previously monopolized by the Bcl-2 family. Future studies will hopefully determine how the IAPs function relative to the apoptotic proteases of the ICE/CED-3 family.
Igniting apoptosis
Studies of C. elegans have provided insights into the effectors and the negative regulators -the 'engine' and 'brakes', respectively -of the cell-death machine. Another invertebrate, Drosophila melanogaster, has been useful in understanding how a dormant cell-death machine may be activated [89] . Genetic analyses of Drosophila have identified a gene, reaper, important in triggering the apoptotic program [89] . The reaper gene encodes a 65-residue polypeptide that is upregulated during Drosophila cell death [89] . It is unlikely that reaper is a death effector, as reaper-deficient embryos, although less sensitive to death stimuli, still undergo apoptosis [90] . In addition, recent studies suggest that reaper functions as an upstream activator of ICE/CED-3 homologs [80, 91] . Transgenic flies expressing reaper, under the control of an inducible promoter, are protected from cell death by overexpression of the baculovirus protein p35 [80, 85] , which is thought to target ICE-like proteases. Furthermore, reaper-induced death of Drosophila Schneider cells can be inhibited by the broad-spectrum ICE-inhibitor, N-benzyloxycarbonyl-ValAla-Asp-fluoromethylketone (z-VAD-FMK) [91] . Interestingly, a Drosophila ICE/CED-3 homolog has recently been identified in the Genbank database [7] .
Although no mammalian equivalent of reaper has yet been identified, Reaper shows weak homology to the so-called 'death domain' of certain mammalian proteins [92] . The death domain was first characterized as a region of homology of about 70 amino acids in the 55 kDa TNFR-1 and Fas/APO-1 [93, 94] . TNFR-1 and Fas/APO-1 are type I transmembrane proteins [95, 96] , and their activation is caused by aggregation mediated by the respective ligands or by agonist antibodies [97] [98] [99] . The death domains of TNFR-1 and Fas/APO-1 are required for these receptors to activate the apoptotic program [93, 94] . The apoptotic signal is thought to be transduced by clustering of death domains [100] . Although reaper must be transcriptionally up-regulated to signal death, subsequent oligomerization may also play a role [89] . Like Reaper-induced cell death, cell death induced by TNFR-1 and Fas/APO-1 is blocked by p35 [101] and z-VAD-FMK (our unpublished observation), implicating ICE/CED-3 homologs in both death pathways. An attractive hypothesis is that Fas/APO-1 and TNFR-1 are chimeric molecules evolved from the linkage of a Reaper-like motif to an extracellular domain, allowing for direct activation of the cell-death machinery by cytokines [92] .
Reaper is also weakly homologous to FADD and TRADD, the intracellular signaling molecules used by Fas/APO-1 and TNFR-1, respectively (reviewed in [102, 103] ). Both FADD and TRADD contain death domains and, on overexpression, they activate the death pathway [104] [105] [106] . Endogenous FADD and TRADD associate with their respective receptors in a ligand-dependent fashion [107, 108] . It has been postulated that TRADD acts as an adaptor molecule that mediates the interaction of TNFR-1 with FADD [107] . A dominant-negative version of FADD blocks TNF-and Fas/APO-1-induced apoptosis, suggesting that FADD acts as the common conduit for cytokine-mediated cell death [107, 109] . An intriguing possibility is that, because of its similar sequence, function, and cell autonomy, Reaper may represent an ancestral form of FADD and TRADD. One might speculate that the dominant negative version of FADD would block Reaper-induced cell death, suggesting that the cell-death machine is activated or 'ignited' in a similar way in mammals and Drosophila.
Conclusions
Identification of the genes that regulate cell death has propelled the study of apoptosis to the forefront of biomedical research. Components of the cell-death pathway are likely conserved through the evolution of multicellular organisms. Invertebrate model systems have played an important part in the identification of several cell-death genes, but it is becoming apparent that the cell-death machinery in mammals may be more complex because of redundancy. For example, mammalian homologs of ced-9 include bcl-2, bcl-x L , bax and bak. Similarly, a family of novel and diverse cysteine proteases related to the death effector ced-3 have been identified, a subset of which is likely to have an important role in the apoptotic mechanism. The cell-death machine is composed of a number of parts (or gene products), including activators, effectors and negative regulators. Discovering how the individual components interact is breathing new life into the study of cell death.
